Coronavirus vaccines may be available in the fall for 6-month-old children in the United States, according to pharmaceutical companies. Pfizer and Moderna test vaccines in children under 12 years of age By September, results will be available for children aged 5 to 11 years.
Compared to adults, children are much less likely to get a serious illness after being infected with the coronavirus. However, nearly 4 million children in the United States have tested positive for the virus since the outbreak of the pandemic. American Academy of Pediatrics..
Doctors continue to see rare cases. Pediatric multisystem inflammatory syndrome in childrenA condition associated with Covid-19 that can affect multiple organs, including the heart. Vaccination of children should further contribute to the containment of the virus by reducing its spread in the community.
Pfizer announced on Tuesday that it will test the vaccine in children aged 5 to 12 years. In the coming weeks, we plan to begin testing vaccines in 6-month-old babies.
the company I would like to apply Pfizer spokeswoman Kit Longley said the results for children aged 2 to 5 could come soon afterwards.
Longley added that data from trials for children aged 6 months to 2 years could arrive in October or November and be submitted to the FDA shortly thereafter.
The Pfizer-BioNTech vaccine was approved for use in children aged 12 to 15 last month.
Based on data from previous studies that evaluated safety, Pfizer gave children aged 5 to 11 two doses of 10 micrograms, one-third of the dose given to adolescents and adults. , Give each child 2 doses of 3 micrograms 6 months to 5 years.
Dr. Bill Gruber, Senior Vice President of Pfizer, said:
The study enrolls up to 4,500 children in more than 90 clinical facilities in the United States, Finland, Poland and Spain. Pfizer researchers will submit complete test data this summer for publication in a peer-reviewed journal.
In March, Moderna began testing various doses of vaccines. Young childrenThe study aimed to enroll 6,750 healthy children in the United States and Canada. Results are not expected until late summer, and the FDA’s approval of the vaccine will take longer.
Moderna CEO Stephane Bancel said on Monday, “I think it will be early fall just because we have to age very slowly and carefully.
The company announced at the end of last month that its vaccine had a strong effect between the ages of 12 and 17 and plans to apply to the FDA for approval in that age group. Last week, Moderna called on authorities to fully approve the vaccine, rather than the currently licensed emergency use.
The United States is not the first country in the world to license a coronavirus vaccine for infants.Approved by China Sinovac vaccine for children According to the company’s chairman, he is only three years old. Approval has not been officially announced.
In the United States, the youngest vaccine is planned for this fall.
Source link In the United States, the youngest vaccine is planned for this fall.